DTx Pharma Announces Presentations at Several Upcoming Virtual Medical Meetings

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company will be presenting at several upcoming virtual medical meetings.